← Leaderboards
Caleb P Skipper
University Of Minnesota
$1,040,982
Attributed
$1,198,923
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $643.5K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$1,198,923 · 3
By mechanism
R21$719,943 · 2
K23$478,980 · 1
Top collaborators
- Simon Arunga1 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- David R Boulware$24,302,588
- Jeffrey S Miller$32,066,338
- Martin Felices$2,733,593
- Melanie Rae Nicol$2,326,366
- Kristina Stoermer Burrack$1,321,335
Others in their field
Other Rising Stars on “Collaborations”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Gary Mays · Axle Informatics, Llc$65,040,187
- Mari Ostendorf · University Of Washington$51,931,230
- Richard Smith · Medical Device Innovation Consortium$41,401,350
- Jeffrey Leintz · National Opinion Research Center$38,969,238
- Brian Zavertnik · Palantir Technologies, Inc.$37,240,166
Research focus
CollaborationsDesignMinnesotaCryptococcal MeningitisMortalityMeningitisPersonsUniversitiesDiagnosisResource-Limited SettingOpportunistic InfectionsAfricaClinical TrialsMeasurementOrganHigh RiskCentral Nervous System InfectionsHiv/AidsCryptococcusCellsEnrollmentFutureCytomegalovirusCessation Of Life
Grant awards (4)
Improving diagnosis of High ICP in Cryptococcal meningitis (ICP-CRYPTO)$404,060
R21 · FY2025 · AI · contact PI
Impact of longitudinal CMV viremia on opportunistic neuroinfections in advanced HIV disease$239,490
K23 · FY2025 · NS · contact PI
Impact of longitudinal CMV viremia on opportunistic neuroinfections in advanced HIV disease$239,490
K23 · FY2024 · NS · contact PI
Identifying CMV Retinitis as a Reversible Cause of Vision Loss in Persons with HIV-associated Meningitis$315,883
R21 · FY2023 · EY · contact PI